BIOCAD sell "Rituximab"
Basic Information
740
33
5
4.1(23)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Rituximab
Details
Specifications
- Assay: Potency confirmed by CD20-binding assay
- Purity: High-purity monoclonal antibody meeting biosimilar quality standards
- Impurity Profile: Aggregates and process-related impurities characterized and controlled per biosimilar guidelines
- Clarity of Solution: Clear to slightly opalescent injectable solution, visually inspected for particulates
Other Information
Additional Description:
This rituximab biosimilar is a chimeric monoclonal antibody that specifically binds the transmembrane antigen CD20, indicated for non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA). It has treated over 60,000 patients, with more than 700,000 vials sold, and is marketed in 19 countries.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment